Showing Results for
From:PLoS ONE (Vol. 16, Issue 9) Peer-ReviewedBackground In the United States, both cannabis use disorder (CUD) and opioid use disorder (OUD) have increased in prevalence. The prevalence, demographics, and costs of CUD and OUD are not well known in heart failure...
From:Cell (Vol. 184, Issue 1) Peer-ReviewedAbstract Only
From:PLoS ONE (Vol. 15, Issue 12) Peer-ReviewedImportance Patient outcomes in heart failure clinical trials are generally better than those observed in real-world settings. This may be related to stricter inclusion and exclusion criteria in clinical trials....
From:PLoS ONE (Vol. 15, Issue 9) Peer-ReviewedBackground Patients with comorbid conditions have a higher risk of mortality with SARS-CoV-2 (COVID-19) infection, but the impact on heart failure patients living near a disease hotspot is unknown. Therefore, we...
From:Annals of Emergency Medicine (Vol. 76, Issue 4) Peer-ReviewedAbstract Only
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it